Report

Global Adhesion Barrier Market Size study, by Product (Synthetic Adhesion Barrier and Natural Adhesion Barrier), by Formulation Outlook (Film Formulations, Gel Formulations and Liquid Formulations), by Applications (Gynaecological Surgeries, Abdominal General Surgeries, Orthopaedic Surgeries, Cardiovascular Surgeries, Neurological Surgeries, Urological Surgeries and Others), and Regional Forecasts 2021-2027.

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Global Adhesion Barrier Market to reach USD 855 million by 2027.Global Adhesion Barrier Market is valued approximately at USD 530 million in 2020 and is anticipated to grow with a healthy growth rate of more than 7.1% over the forecast period 2021-2027. Growth in the incidences of surgeries and sports-related injuries and rising awareness regarding the medical implications of adhesions are the factors which are driving the growth of Adhesion Barrier market. Furthermore, development of medical infrastructure and increasing number of trauma centers will be anticipating the growth of market in forecasted period. For instance: in December 2019, Baxter's has acquired the Seprafilm adhesion barrier and other shares from Sanofi, which is a major key player in the market; this strategy will strengthen the company's presence in this market. However, strict rules and regulations resulting in limited technological innovations may impede market growth over the forecast period of 2021-2027.

Global Adhesion Barrier market analysis on basis of region which includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a significant region across the world in terms of market share due to high adoption of advanced treatment procedures in the region. Whereas Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to increasing development in medical infrastructure in the region.
Major market player included in this report are:
Sanofi S.A.
Becton, Dickinson and Company
Baxter International, Inc.
Johnson and Johnson
Anika Therapeutics, Inc.
Fzio Med, Inc
Mast Biosurgery, Inc.
Innocoll Holdings PLC
Atrium Medical Corporation
Integra LifeSciences
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Synthetic Adhesion Barriers
Hyaluronic acid
Regenerated cellulose
Polyethylene glycol
Others
Natural Adhesion Barriers
Collagen & Protein
Fibrin
By Formulation Outlook
Film Formulations
Gel Formulations
Liquid Formulations
By Applications
Gynecological Surgeries
Abdominal General Surgeries
Orthopedic Surgeries
Cardiovascular Surgeries
Neurological Surgeries
Urological Surgeries
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Adhesion Barrier Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors